Radiopharm Theranostics and SHINE Technologies Announce Clinical Supply Agreement for Cancer-Fighting Medical Isotope ...Middle East

SHINE to supply n.c.a. lutetium-177 for the clinical development of multiple programs for Radiopharm Theranostics JANESVILLE, Wis. and SYDNEY, Sept. 19, 2022 /PRNewswire/ -- SHINE Technologies, a next-generation fusion technology company, and Radiopharm Theranostics (ASX:RAD), a developer...

Hence then, the article about radiopharm theranostics and shine technologies announce clinical supply agreement for cancer fighting medical isotope was published today ( Tuesday 20/09/2022 - 03:28 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Radiopharm Theranostics and SHINE Technologies Announce Clinical Supply Agreement for Cancer-Fighting Medical Isotope )

Also on site :

• Iranian Foreign Minister spokesperson in exclusive interview discusses cause of the war and Iran’s stance
• Walmart’s 'Very Sturdy' $53 3-Piece Patio Set Is Perfect for Small-Space Entertaining
• ‘Inflationary surge’: Fed economists warn AI hype is overheating the economy whether or not the technology ever delivers